Patient-specific Virtual Reality Rehearsal Prior to EVAR: Influence on Technical and Non-technical Operative Performance

December 13, 2022 updated by: University Hospital, Ghent

Patient-specific Virtual Reality Rehearsal Prior to EVAR: Influence on Technical and Non-technical Operative Performance. A Randomized Controlled Trial.

Ongoing technological advances, especially in the field of image processing, have refined medical simulations to offer life-like replications of medical and surgical procedures in a variety of specialties. Patient-specific image data are incorporated into these simulations, and transformed into a 3D model. This enables the practitioner and his/her team to perform and practice 'real' cases on a virtual patient prior to performing the real procedure on the actual patient. This new technology has been referred to as 'patient-specific' rehearsal, also 'mission' or 'procedure' rehearsal.

Research has already proven that simulated patient-specific rehearsal of a carotid artery stenting procedure may enhance surgical and team performance.

The PROcedure rehearsal software can now also be used to practice patient-specific endovascular repair of infrarenal aortic aneurysms (EVAR). The ability to rehearse a challenging and complex procedure like EVAR may not only influence device selection based on preoperative planning, but also improve the technical performance of the surgeon/radiologist and the awareness and communication within the entire endovascular team. However, further research is needed to evaluate if this new technology may enhance clinical safety and efficiency, i.e. if patients actually benefit from physicians and team members conducting patient-specific rehearsals of EVAR interventions.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Duffel, Belgium, 2570
        • Sint - Maarten Hospital, Campus Rooienberg
      • Ghent, Belgium, 9000
        • Ghent University Hospital
      • Zurich, Switzerland, 8091
        • Zurich University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with an infrarenal aortic aneurysm suitable for endovascular exclusion. The suitability for endovascular repair is based upon the physician's decision.

Description

Inclusion Criteria:

-infrarenal aortic aneurysm suitable for endovascular exclusion

Exclusion Criteria:

  • Adult patients who do not have capacity to consent.
  • Previous stent-graft implanted in the abdominal aorta

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
PROcedure rehearsal
PROcedure rehearsal performed before real EVAR procedure No intervention
No PROcedure rehearsal
no PROcedure rehearsal performed before real EVAR procedure No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technical operative metrics
Time Frame: during EVAR procedure
  • C-arm positioning for proximal and distal landing zone
  • Fluoroscopy time
  • Number of angiograms
  • Amount of contrast
during EVAR procedure
Errors occurring during EVAR procedure (Imperial College Error Capture record)
Time Frame: during EVAR procedure
during EVAR procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective sense of realism of patient-specific rehearsal reported by team members
Time Frame: immediately after EVAR procedure
Subjective sense of realism of patient-specific rehearsal reported by team members (Measurement: questionnaire)
immediately after EVAR procedure
Team satisfaction
Time Frame: immediately after EVAR procedure
Team satisfaction Measurement: questionnaire
immediately after EVAR procedure
Any deviation from initial treatment plan
Time Frame: immediately after EVAR procedure
immediately after EVAR procedure
30 day mortality and morbidity
Time Frame: within the first 30 days after surgery
within the first 30 days after surgery
Technical and clinical success rate
Time Frame: immediately after EVAR procedure
  • Successful access to the arterial system using a remote site
  • Successful deployment of the endoluminal graft with secure proximal and distal fixation
  • Absence of either type I or III endoleak
  • Patent endoluminal graft without significant twist, kinks, or obstruction
immediately after EVAR procedure
Initial clinical success
Time Frame: within the first 30 days after surgery

o Successful deployment of the endovascular device at the intended location, without:

  • Death as a result of aneurysm-related treatment
  • Type I or III endoleak
  • Graft infection or thrombosis
  • Aneurysm expansion (diameter > 5mm)
  • Aneurysm rupture
  • Conversion to open repair
  • Graft dilatation (≥ 20% by diameter)
  • Graft migration
  • Failure of device integrity
within the first 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Liesbeth Desender, University Hospital, Ghent

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2012

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

June 28, 2012

First Submitted That Met QC Criteria

July 2, 2012

First Posted (Estimate)

July 3, 2012

Study Record Updates

Last Update Posted (Estimate)

December 14, 2022

Last Update Submitted That Met QC Criteria

December 13, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EC/2012/412

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infrarenal Aortic Aneurysm

Subscribe